BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25499307)

  • 1. Optical coherence tomography assessment of late intra-scaffold dissection: a new challenge of bioresorbable scaffolds.
    Ohno Y; Mangiameli A; Attizzani GF; Capodanno D; Tamburino C
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e11-2. PubMed ID: 25499307
    [No Abstract]   [Full Text] [Related]  

  • 2. Two-Year Follow-Up OCT Images of 2 Bifurcation Lesions Treated With Bioresorbable Vascular Scaffolds.
    Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Latib A; Colombo A
    JACC Cardiovasc Imaging; 2015 May; 8(5):617-618. PubMed ID: 25457765
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe Neointimal Hyperplasia of Neoplastic Carina Following Bioresorbable Scaffold Implantation Using T-Stenting and Small Protrusion Technique: Insights From Optical Frequency Domain Imaging.
    Kawamoto H; Ruparelia N; Figini F; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Nov; 8(13):e207-9. PubMed ID: 26476605
    [No Abstract]   [Full Text] [Related]  

  • 4. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
    Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
    [No Abstract]   [Full Text] [Related]  

  • 5. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruptured neoatherosclerosis presenting as a large intrastent neointimal dissection.
    Rivero F; Cuesta J; Benedicto A; Bastante T; Alfonso F
    JACC Cardiovasc Interv; 2014 Nov; 7(11):e169-70. PubMed ID: 25459046
    [No Abstract]   [Full Text] [Related]  

  • 9. Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography.
    Sato T; Richardt G; Abdel-Wahab M
    Coron Artery Dis; 2016 Nov; 27(7):616-7. PubMed ID: 27228185
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed disruption of a bioresorbable vascular scaffold.
    Naganuma T; Latib A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):845-7. PubMed ID: 25124018
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis.
    Bastante T; Rivero F; Benedicto A; Cuesta J; Alfonso F
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1264-1265. PubMed ID: 26292592
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomechanical assessment of fully bioresorbable devices.
    Gogas BD; King SB; Timmins LH; Passerini T; Piccinelli M; Veneziani A; Kim S; Molony DS; Giddens DP; Serruys PW; Samady H
    JACC Cardiovasc Interv; 2013 Jul; 6(7):760-1. PubMed ID: 23866188
    [No Abstract]   [Full Text] [Related]  

  • 13. Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry.
    Longo G; Granata F; Capodanno D; Ohno Y; Tamburino CI; Capranzano P; La Manna A; Francaviglia B; Gargiulo G; Tamburino C
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1150-61. PubMed ID: 25573598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold at 8 Months.
    Kang SH; Kang SJ; Kim WJ
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1896-1898. PubMed ID: 28866035
    [No Abstract]   [Full Text] [Related]  

  • 15. Coregistered intravascular ultrasound and optical coherence tomography imaging during implantation of a bioresorbable vascular scaffold.
    Brown AJ; McCormick LM; Hoole SP; West NE
    JACC Cardiovasc Interv; 2013 Jul; 6(7):e41-2. PubMed ID: 23866193
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery.
    Gargiulo G; Longo G; Capodanno D; Francaviglia B; Capranzano P; Tamburino C
    JACC Cardiovasc Interv; 2015 May; 8(6):e95-e97. PubMed ID: 25999117
    [No Abstract]   [Full Text] [Related]  

  • 17. Anatomic stabilization and functional normalization of a ruptured coronary plaque 12 months after implantation of a bioresorbable scaffold.
    Gori T; Schulz E; Münzel T
    JACC Cardiovasc Interv; 2014 May; 7(5):e47-8. PubMed ID: 24746656
    [No Abstract]   [Full Text] [Related]  

  • 18. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
    Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457
    [No Abstract]   [Full Text] [Related]  

  • 19. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.